April 2015

Features

Alternatives to topical drops appear to be effective—and they’re becoming more popular.

Researchers are exploring disease-modifying treatment options and not just symptomatic relief.

Your initial due diligence when considering a medical start-up should include these steps.

Surgeons need some questions answered before they’ll embrace the procedure.

Balancing demands for cost-cutting while maintaining high quality requires keeping patients’ interests front and center.

Imaging often reserved for laser refractive surgery patients can help evaluate premium intraocular lens candidates, as well.

Changes to the participation bonus, new ophthalmic measures and requirements that can affect future reimbursements.

Advances in optical coherence tomography reveal correlations between retinal anatomy and vision loss in several retinal diseases.

Preservatives such as BAK can be hard on your patients’ corneas, but the alternatives sometimes raise practical concerns.

The exciting world of stem cell therapy is the cutting edge of medical research. Here’s how it intersects with ophthalmology.

The advent of MIGS may change the equation about what’s the best initial therapy for patients with open-angle glaucoma.

As the most powerful refracting element of the eye, the air/tear interface deserves a lot of preoperative attention, surgeons say.

A young infant is brought to Wills for evaluation of increased pigmentation and associated nodular lesions in her right eye.